吉兰-巴雷综合征:免疫病原发生和治疗点
Shan Liu1, Wei Wei Zhang2, Linpei Jia3
1Department of Nuclear Medicine, Second Hospital of Jilin University, Changchun, China.
Expert opinion on therapeutic targets
|March 12, 2024
概括
吉兰-巴雷综合征 (GBS) 是一种影响神经的免疫疾病. 虽然研究了像SARS-CoV-2这样的触发剂,但目前的IVIg和血交换等治疗方法的疗效有所变化,需要对新疗法的进一步研究.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 吉兰-巴雷综合征 (GBS) 是一种急性免疫媒介外周神经系统疾病.
- 传染性和非传染性因素可以触发自身免疫反应,导致GBS的神经损伤.
研究的目的:
- 审查关于GBS免疫病原发生的当前知识,特别是在COVID-19的背景下.
- 总结已确定的和潜在的GBS免疫调节疗法.
主要方法:
- 关于GBS免疫病原发生和治疗的文献综述.
- 分析SARS-CoV-2和GBS之间的关联.
- 免疫调节疗法的总结,包括IVIg,PE和皮质类固醇.
主要成果:
- SARS-CoV-2 和 GBS 之间的关联是不确定的,并且显示出地理差异.
- 针对GBS的第一线疗法 (IVIg,PE) 的有效性可以根据亚型和严重程度变化.
- 新疗法在动物模型中显示出前景,但需要临床验证.
结论:
- 需要进一步的研究来澄清GBS触发因素,并优化治疗策略.
- 缺乏指导方针来治疗轻度受影响的GBS患者或具有区域亚型的患者.
- 研究新的免疫调节疗法对于改善GBS患者的治疗结果至关重要.
更多相关视频
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
11.5K
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
12.2K
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
01:15Myasthenia Gravis: Diagnostic Tests
831
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
831